A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

NCT01654536 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

737

Enrollment

INDUSTRY

Sponsor class

Conditions

Perennial Allergic Rhinitis

Interventions

DRUG: ciclesonide nasal aerosol
DRUG: ciclesonide nasal spray

Sponsor

Sumitomo Pharma America, Inc.